---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-002805"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2024-02-01T23:59:59+00:00"
generated_at: "2026-06-06T12:10:25.344491+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health Q2 revenue up 12% to $57.4B; non-GAAP EPS $1.82 (+38%); FY24 guidance raised

## Summary
- GAAP diluted EPS $1.43 vs. $(0.50) prior year; non-GAAP operating earnings $562M, up 20%.
- Pharmaceutical segment profit $518M (+12%); Medical segment profit $71M vs. $17M.
- FY24 non-GAAP EPS guidance raised to $7.20-$7.35 from $6.75-$7.00; adj. free cash flow ~$2.5B.
- Announced acquisition of Specialty Networks, a tech-enabled multi-specialty GPO and practice enhancement organization.
- Revenue $57.4B, driven by brand/specialty pharmaceutical sales growth and COVID-19 vaccine distribution.

## SEC filing metadata
- accession: 0001628280-24-002805
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2024-02-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000162828024002805/0001628280-24-002805-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000162828024002805/cah-20240201.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-002805
- JSON: https://secwatch.observer/filing/0001628280-24-002805.json
- Plain text: https://secwatch.observer/filing/0001628280-24-002805.txt

## Key facts
- Earnings Releases
  CARDINAL HEALTH INC reported the quarter ended December 31, 2023 results: revenue $57.4 billion, EPS $1.43. Guidance raised.
  - Period: the quarter ended December 31, 2023
  - Revenue: $57.4 billion
  - EPS: $1.43
  - Guidance: raised
  - Result: reported results
  source text: report. --- EX-99.1 (EX-99.1) --- FOR IMMEDIATE RELEASE Cardinal Health Reports Second Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook • Revenue increased 12% to $57.4 billion • GAAP 1 operating earnings were $482 million; GAAP diluted EPS was $1.43 • Non-GAAP operating earnings increased 20% to $562 million; non-GAAP diluted EPS increased 38% to $1.82
  evidence_url: https://www.sec.gov/Archives/edgar/data/721371/000162828024002805/0001628280-24-002805-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.